VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats

Nu.Q® Vet Cancer TestPositive

AI Analysis

Summary

VolitionRx announced submission of a manuscript for its Nu.Q® Vet Cancer Test in cats for peer-reviewed publication, which is expected to trigger a $5 million contractual milestone payment upon publication.

Outcome Details

Manuscript submission for peer-reviewed publication; $5 million contractual milestone payment expected upon publication

Importance:4/10

Sentiment:

0.60

manuscript_submissionveterinary_diagnosticsmilestone_paymentepigenetics

Related Companies

$VNRX

Read the original article

Published by PR Newswire Clinical Trials on May 6, 2026 12:17 PM

Read Original